title: Clinical and angiographic results with the ACS MULTI-LINK DUET trade mark Coronary Stent System - the DUET Study.
abstract: BACKGROUND: The DUET Study is a multicenter prospective efficacy and safety evaluation of the ACS MULTI-LINK DUET coronary stainless steel balloon-expandable stent. AIMS: The primary objective was to determine the one-month incidence of MACE (major adverse cardiac events). The secondary objectives were the acute success rate, the restenosis and reocclusion rates (assessed by quantitative coronary angiography (QCA)) at six months and the occurrence of MACE in hospital and at six months. METHODS: Two hundred and ten patients were enrolled between February and June 1998 in 18 European centers. Successful stent placement was achieved in 209 patients. All patients were treated with ticlopidine 500 mg/day for one month and with aspirin >/=100 mg/day. To allow the investigators to gain familiarity with the stent system, the first one to three patients per center formed a separate lead-in population leaving an intention-to-treat population of 157 patients. The majority of the intention-to-treat population were male (79%); 28% had unstable angina, 69% had stable angina, 44% had had a previous myocardial infarction, 15% had had a previous percutaneous transluminal coronary angioplasty, and 3% had a history of stroke. The target vessel was 38.5% left anterior descending artery, 20.5% left circumflex artery and 41.0% right coronary artery. RESULTS: All but one of the intention-to-treat patients were effectively stented (17 required multiple stents). Six-month angiographic follow-up was available in 90% of the intention-to-treat population. Minimal lumen diameter (MLD) postprocedure was 2.61 +/- 0.33 mm, with a residual diameter stenosis of 16%. Six-month follow-up data showed an MLD of 1.87 +/- 0.56 mm with a residual diameter stenosis of 36%. The binary restenosis rate (>/=50% residual stenosis) was 15.6%. Up to one month following the procedure 94.9% of the population was MACE-free, with two subacute occlusions. At six months all patients were alive, of whom 82.8% were MACE-free, and 73% were free of anginal complaints. CONCLUSION: The results observed in the current DUET registry are comparable to data of other balloon-expandable-stent trials, with a low incidence of clinical events at follow-up.
authors.affiliation: Division of Cardiology, Ignatius Hospital, PO Box 9015, 4800 RK Breda, The Netherlands.
authors.forename: J AM
authors.initials: JA
authors.lastname: Te Riele
authors.forename: J J
authors.initials: JJ
authors.lastname: Piek
authors.forename: H
authors.initials: H
authors.lastname: Mudra
authors.forename: C W
authors.initials: CW
authors.lastname: Hamm
authors.forename: J
authors.initials: J
authors.lastname: Schofer
authors.forename: M
authors.initials: M
authors.lastname: Bertrand
authors.forename: W
authors.initials: W
authors.lastname: Rutsch
authors.forename: J A
authors.initials: JA
authors.lastname: Beekman
authors.forename: S
authors.initials: S
authors.lastname: Veldhof
authors.forename: M HJ
authors.initials: MH
authors.lastname: Eijgelshoven
authors.forename: P W
authors.initials: PW
authors.lastname: Serruys